CNO Financial Group, Inc.
CNOFinancial ServicesNASDAQInsurance - Life
Scan Results
Daily timeframeHeadquartered within the financial services sector, CNO Financial Group, Inc. focuses on Insurance - Life services and products. CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance and other insurance products, and financial services for. At a $4.96B market cap, CNO Financial Group, Inc. ranks as a mid-cap company within financial services. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individual consumers through phone, virtually, online, and face-to-face with agents.
Market Cap
$4.96B
Beta
0.81
P/E (TTM)
18.57
P/E (Fwd)
10.60
EPS (TTM)
$2.89
EPS (Fwd)
$5.06
ROE
10.9%
ROA
1.1%
Cash
$1.55B
Total Debt
$4.55B
Free CF
$996.1M
52W Change
33.8%
Annual Financials
Cash vs Debt
Where CNO stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, CNO finished 8.75% above its 150-day moving average ($49.72) and 13.35% above its 200-day moving average ($47.70). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CNO overbought or oversold?
At the October 20, 2026 close, CNO's RSI(14) was 56.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $1.55B in cash, though total debt stands at $4.55B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $996.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 10.9% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 1.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $3.58B (2022) to $4.49B (2025), reflecting a 25% increase over the period.
As with any equity investment, CNO carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. No single metric tells the full story. Reviewing CNO's risk profile alongside its fundamentals and technical indicators provides a more complete picture.